Pfizer Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk.
In This Article:
The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.